Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil

Primary CoronaVac vaccination followed by a BNT162b2 booster dose confers protection against some SARS-CoV-2 variants but its effectiveness against Omicron is unknown. Here, the authors show that this combination confers a high level of protection against severe outcomes for up to 120 days, with evi...

Full description

Bibliographic Details
Main Authors: Thiago Cerqueira-Silva, Vinicius de Araujo Oliveira, Enny S. Paixão, Juracy Bertoldo Júnior, Gerson O. Penna, Guilherme L. Werneck, Neil Pearce, Maurício L. Barreto, Viviane S. Boaventura, Manoel Barral-Netto
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-31839-7
_version_ 1818190122376495104
author Thiago Cerqueira-Silva
Vinicius de Araujo Oliveira
Enny S. Paixão
Juracy Bertoldo Júnior
Gerson O. Penna
Guilherme L. Werneck
Neil Pearce
Maurício L. Barreto
Viviane S. Boaventura
Manoel Barral-Netto
author_facet Thiago Cerqueira-Silva
Vinicius de Araujo Oliveira
Enny S. Paixão
Juracy Bertoldo Júnior
Gerson O. Penna
Guilherme L. Werneck
Neil Pearce
Maurício L. Barreto
Viviane S. Boaventura
Manoel Barral-Netto
author_sort Thiago Cerqueira-Silva
collection DOAJ
description Primary CoronaVac vaccination followed by a BNT162b2 booster dose confers protection against some SARS-CoV-2 variants but its effectiveness against Omicron is unknown. Here, the authors show that this combination confers a high level of protection against severe outcomes for up to 120 days, with evidence of waning for those aged 80 or older.
first_indexed 2024-12-11T23:53:42Z
format Article
id doaj.art-ae64e24901e447b89414616d84f2020e
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-11T23:53:42Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-ae64e24901e447b89414616d84f2020e2022-12-22T00:45:24ZengNature PortfolioNature Communications2041-17232022-07-011311610.1038/s41467-022-31839-7Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in BrazilThiago Cerqueira-Silva0Vinicius de Araujo Oliveira1Enny S. Paixão2Juracy Bertoldo Júnior3Gerson O. Penna4Guilherme L. Werneck5Neil Pearce6Maurício L. Barreto7Viviane S. Boaventura8Manoel Barral-Netto9LIB and LEITV Laboratories, Instituto Gonçalo Moniz, FiocruzUniversidade Federal da BahiaLondon School of Hygiene and Tropical MedicineUniversidade Federal da BahiaNúcleo de Medicina Tropical, Universidade de Brasília. Escola Fiocruz de GovernoUniversidade do Estado do Rio de JaneiroLondon School of Hygiene and Tropical MedicineUniversidade Federal da BahiaLIB and LEITV Laboratories, Instituto Gonçalo Moniz, FiocruzLIB and LEITV Laboratories, Instituto Gonçalo Moniz, FiocruzPrimary CoronaVac vaccination followed by a BNT162b2 booster dose confers protection against some SARS-CoV-2 variants but its effectiveness against Omicron is unknown. Here, the authors show that this combination confers a high level of protection against severe outcomes for up to 120 days, with evidence of waning for those aged 80 or older.https://doi.org/10.1038/s41467-022-31839-7
spellingShingle Thiago Cerqueira-Silva
Vinicius de Araujo Oliveira
Enny S. Paixão
Juracy Bertoldo Júnior
Gerson O. Penna
Guilherme L. Werneck
Neil Pearce
Maurício L. Barreto
Viviane S. Boaventura
Manoel Barral-Netto
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
Nature Communications
title Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
title_full Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
title_fullStr Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
title_full_unstemmed Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
title_short Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
title_sort duration of protection of coronavac plus heterologous bnt162b2 booster in the omicron period in brazil
url https://doi.org/10.1038/s41467-022-31839-7
work_keys_str_mv AT thiagocerqueirasilva durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT viniciusdearaujooliveira durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT ennyspaixao durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT juracybertoldojunior durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT gersonopenna durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT guilhermelwerneck durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT neilpearce durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT mauriciolbarreto durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT vivianesboaventura durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil
AT manoelbarralnetto durationofprotectionofcoronavacplusheterologousbnt162b2boosterintheomicronperiodinbrazil